Maya Khodor Khalil

Maya Khalil practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Maya Khalil's NPI, 1053726430, was assigned on June 24, 2014. Maya Khalil holds Alabama license 39317.

Maya Khalil's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Maya Khalil's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Maya Khalil is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Maya Khalil practices. Vendor and product names are available with a free account.

Hematology and oncology is Maya Khalil's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Maya Khalil is licensed in Alabama.

CMS data shows 516 Medicare services from Maya Khalil across 3 procedure codes in 2024, for 123 Medicare patients. Medicare paid $30,139 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Maya Khalil in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have cancer, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maya Khalil's median patient age at 69, with 56% women.

In 2024, Maya Khalil wrote 585 Medicare Part D claims for 128 patients. 79% of them were for generic drugs. CMS names the drug for 389 of them, across 16 drugs with 11 or more claims each, at $590,521 in total drug cost. In 2023, CMS named 680 claims across 25 drugs.

Maya Khalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Maya Khalil as offering telehealth.

Dmand AI links 8 papers to Maya Khalil, published from 2015 to 2025. 2015 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Maya Khalil has published most often in J Natl Compr Canc Netw. Maya Khalil's most frequent co-authors are Eugene R. Ahn, MD, Michael F. Bassetti and Collin M. Blakely, MD.

Dmand AI links Maya Khalil to 4 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Neuroendocrine, Carcinoma, Non-Small-Cell Lung and Melanoma. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 7 general payments to Maya Khalil from 6 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 63% of the total. Astellas Pharma US Inc paid the most, $165.